0.00
100.00%
-70.98
Handel nachbörslich:
70.95
70.95
+
Axonics Inc Aktie (AXNX) Neueste Nachrichten
Boston Scientific stock holds rating after Axonics acquisition - Investing.com
UroMems Appoints Former Axonics Executive Rinda Sama to Board of Directors - PR Newswire UK
Boston Sci. Completes $3.7B Axonics Buy - Orange County Business Journal
Thibodaux Regional Urology Clinic Recognized as an Axonics® Center of Excellence - Lafourche Gazette
Boston Scientific Stock Set to Gain From Completion of Axonics Deal - MSN
Axonics, Inc. (NASDAQ:AXNX) Stock Holdings Raised by Alpine Associates Management Inc. - MarketBeat
Axonics Modulation Technologies (AXNX) Q3 Earnings and Revenues Top Estimates - MSN
Boston Scientific Completes $3.7B Acquisition of Axonics - Orange County Business Journal
Boston Scientific Completes Strategic Acquisition of Axonics - Zenopa
LMR Partners LLP Reduces Stock Holdings in Axonics, Inc. (NASDAQ:AXNX) - MarketBeat
Boston Scientific Completes Acquisition of Axonics - Zenopa
Boston Scientific acquires Axonics - Medical Buyer
Boston Scientific Closes Acquisition of Axonics - FinSMEs
SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of its Board of Directors - The Manila Times
Short Interest in Axonics, Inc. (NASDAQ:AXNX) Grows By 5.4% - MarketBeat
Boston Scientific (BSX) Completes Acquisition of Axonics - GuruFocus.com
Boston Scientific completes $3.7B purchase of California bowel dysfunction company - Worcester Business Journal
Boston Scientific finalizes $3.7B acquisition of Axonics - Mass Device
Boston Scientific closes $3.7B Axonics deal after lengthy review - MedTech Dive
Boston Sci Closes Acquisition of Medtronic’s Neuromodulation Foe - MD+DI
Boston Scientific Closes $3.7B Deal for Axonics - MPO-mag
Boston Scientific closes acquisition of Axonics, Inc - Med-Tech Innovation
Axonics Modulation Technologies Merges and Delists from Nasdaq - TipRanks
Axonics, Inc. Announces Management Changes - Marketscreener.com
Boston Scientific Completes $3.7B Axonics Acquisition, Expands Urology Portfolio | BSX Stock News - StockTitan
Axonics, Inc. (NASDAQ:AXNX) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Axonics stock soars to 52-week high, reaches $70.93 By Investing.com - Investing.com Australia
Axonics stock soars to 52-week high, reaches $70.93 - Investing.com India
Axonics gains after Nasdaq delisting notice for sale to Boston Scientific - MSN
SoniVie Names Axonics' Raymond Cohen as Chairman Following $3.7B Boston Scientific Deal | BSX Stock News - StockTitan
Versor Investments LP Sells 30,587 Shares of Axonics, Inc. (NASDAQ:AXNX) - MarketBeat
Axonics’ Q3 2024: Revenue Growth Amid Challenges - TipRanks
Axonics' (AXNX) "Hold" Rating Reiterated at Needham & Company LLC - MarketBeat
Axonics: Q3 Earnings Snapshot - Houston Chronicle
Axonics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Axonics Reports Third Quarter 2024 Financial Results - BioSpace
Axonics Inc (AXNX) Q3 2024 Earnings: Revenue Hits $116.2 Million, Surpassing Estimates - GuruFocus.com
Medtronic Says Axonics Misled Jury To Beat Patent Case - Law360
Axonics stock soars to 52-week high, reaches $70.6 - Investing.com
Axonics stock soars to 52-week high, reaches $70.6 By Investing.com - Investing.com UK
Axonics’ Market Growth Strengthens Boston Scientific’s Future (NASDAQ:AXNX) - Seeking Alpha
Boston Scientific Announces Agreement to Acquire Cortex, Inc. - StockTitan
Axonics, Inc. (NASDAQ:AXNX) Shares Sold by Oak Ridge Investments LLC - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):